Enrichment difference analysis of the genes showing changes after OHT treatment revealed known breast cancer oncogenes such as HDAC3, UBE2C and CPSF7 among the depleted genes and reported breast cancer suppressors such as CSK, SPRED2 and TSC2 among the enriched genes (Fig. 1B). This evidence concerns the gene HDAC3 and breast carcinoma.